Fisher Asset Management decreases position in NuVasive by 0.8%: 4 things to know

Fisher Asset Management reduced its position in NuVasive by 0.8 percent during the fourth quarter, according to a Financial Market News report.

Advertisement

Here are four things to know:

 

1. Fisher Asset Management’s holdings in NuVasive were worth $75.9 million at the end of the most recent quarter.

 

2. The firm has a 50-day moving average price of $46.10 and a 200-day moving average price of $50.36.

 

3. The company has a 12-month low of $36.81 and a 12-month high of $56.61.

 

4. The company has a market cap of $1.94 billion.

 

More articles on devices:
Materialise, Mathys pen agreement — 4 highlights
Amedica to present clinical trial for CASCADE — 5 notes
Arthrex named one of Fortune’s 15 best workplaces for production: 4 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.